These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11520199)

  • 1. Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides.
    Pei Z; Xin Z; Liu G; Li Y; Reilly EB; Lubbers NL; Huth JR; Link JT; von Geldern TW; Cox BF; Leitza S; Gao Y; Marsh KC; DeVries P; Okasinski GF
    J Med Chem; 2001 Aug; 44(18):2913-20. PubMed ID: 11520199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide.
    Winn M; Reilly EB; Liu G; Huth JR; Jae HS; Freeman J; Pei Z; Xin Z; Lynch J; Kester J; von Geldern TW; Leitza S; DeVries P; Dickinson R; Mussatto D; Okasinski GF
    J Med Chem; 2001 Dec; 44(25):4393-403. PubMed ID: 11728185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.
    Liu G; Huth JR; Olejniczak ET; Mendoza R; DeVries P; Leitza S; Reilly EB; Okasinski GF; Fesik SW; von Geldern TW
    J Med Chem; 2001 Apr; 44(8):1202-10. PubMed ID: 11312920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead.
    Liu G; Link JT; Pei Z; Reilly EB; Leitza S; Nguyen B; Marsh KC; Okasinski GF; von Geldern TW; Ormes M; Fowler K; Gallatin M
    J Med Chem; 2000 Oct; 43(21):4025-40. PubMed ID: 11052808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on some p-arylthio cinnamides as antagonists of biochemical ICAM-1/LFA-1 interaction and ICAM-1/JY-8 cell adhesion in relation to anti-inflammatory activity.
    Debnath B; Samanta S; Roy K; Jha T
    Bioorg Med Chem; 2003 Apr; 11(8):1615-9. PubMed ID: 12659746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding.
    Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW
    Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.
    Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G
    Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.
    Zhong M; Hanan EJ; Shen W; Bui M; Arkin MR; Barr KJ; Evanchik MJ; Hoch U; Hyde J; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):307-10. PubMed ID: 21109434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.
    Zhang X; Wojcikiewicz E; Moy VT
    Biophys J; 2002 Oct; 83(4):2270-9. PubMed ID: 12324444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein.
    Jois SD; Teruna TJ
    J Biomol Struct Dyn; 2003 Apr; 20(5):635-44. PubMed ID: 12643766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54).
    Lub M; van Kooyk Y; Figdor CG
    J Leukoc Biol; 1996 May; 59(5):648-55. PubMed ID: 8656049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
    Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
    ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1.
    Fisher KL; Lu J; Riddle L; Kim KJ; Presta LG; Bodary SC
    Mol Biol Cell; 1997 Mar; 8(3):501-15. PubMed ID: 9188101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
    Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
    Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.
    Greenspan PD; Fujimoto RA; Marshall PJ; Raychaudhuri A; Lipson KE; Zhou H; Doti RA; Coppa DE; Zhu L; Pelletier R; Uziel-Fusi S; Jackson RH; Chin MH; Kotyuk BL; Fitt JJ
    J Med Chem; 1999 Jan; 42(1):164-72. PubMed ID: 9888841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion.
    Yusuf-Makagiansar H; Yakovleva TV; Tejo BA; Jones K; Hu Y; Verkhivker GM; Audus KL; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):237-46. PubMed ID: 17718718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA- 1-mediated T-cell adhesion.
    Xu CR; Yusuf-Makagiansar H; Hu Y; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 2002 Apr; 19(5):789-99. PubMed ID: 11922836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding properties of ICAM-1 peptides to LFA-1: inhibitors of T-cell adhesion.
    Anderson ME; Tejo BA; Yakovleva T; Siahaan TJ
    Chem Biol Drug Des; 2006 Jul; 68(1):20-8. PubMed ID: 16923022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.